You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪瑞醫療(300396.SZ):取得3項發明專利證書
格隆匯 10-22 20:32

格隆匯10月22日丨迪瑞醫療(300396.SZ)公佈,公司於近日收到由中華人民共和國國家知識產權局頒發的3項《發明專利證書》,分別為全自動生化儀特定波長標準物及其應用,一種層粘連蛋白校準品及質控品,一種穩定的尿總蛋白質控品及其製備方法應用。

上述專利為公司自主研發,分別應用於公司生化分析、化學發光免疫分析產品線中。全自動生化儀特定波長標準物及其應用可解決以標準物測試波長的全自動生化分析儀部分測光波長標準物缺失、準確性不好的技術問題一種層粘連蛋白校準品及質控品對尿素用於層粘連蛋白校準品質控品的開發起到指導作用一種穩定的尿總蛋白質控品及其製備方法應用解決了尿總蛋白質控品中尿液總蛋白含量低易發生衰減、無法長期保存、穩定性差的問題。上述發明專利的取得不會對公司近期生產經營產生重大影響,但有利於發揮公司自主知識產權技術優勢,完善知識產權保護體系,從而增強公司核心競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account